Related Experiment Video
Updated: Jan 10, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Malignant pertussis in infants: 4 new cases in French Guiana
Cédric Ngila Lubunu1, Christelle Samou-Fontcho1, Urbain Agbessy Awanou1
1Service de pédiatrie, CHU de Guyane, site de Cayenne, 3 avenue Alexis Blaise, Cayenne 97300, French Guiana; Service de pédiatrie, CHU de Guyane, site de Saint-Laurent-du-Maroni, Avenue Paul Castaing, Saint-Laurent du Maroni 97320, French Guiana; Service de médecine et réanimation néonatale, CHU de Guyane, 3 avenue Alexis Blaise, Cayenne 97300, French Guiana.
Insights
Malignant pertussis is a severe condition in infants, causing respiratory failure and high mortality. Vaccination is crucial for preventing these dangerous cases and protecting vulnerable populations.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Malignant pertussis is a severe form of pertussis.
- It is characterized by respiratory distress, polyvisceral failure, and marked hyperlymphocytosis.
- Typical presentations include profound leukocytosis, pulmonary hypertension, and respiratory failure.
Purpose of the Study:
- To report on four cases of malignant pertussis in young infants.
- To highlight the severity and outcomes of this condition.
- To emphasize the importance of vaccination in preventing severe pertussis.
Main Methods:
- Case series reporting on four infants with malignant pertussis.
- Clinical data including presentation, treatment, and outcomes were reviewed.
- One patient received exchange transfusion.
Main Results:
- The case fatality rate in the reported cases was 50%.
- Malignant pertussis presented with severe symptoms including respiratory failure and hyperlymphocytosis.
- The condition is associated with high mortality and significant intensive care costs.
Conclusions:
- Malignant pertussis is a severe and often fatal condition in infants.
- Vaccination is the primary strategy for preventing these severe cases.
- Ensuring infant immunization and extending it to at-risk adults is essential to prevent transmission.
Abstract:
Malignant pertussis is a severe form of pertussis characterized by respiratory distress, polyvisceral failure, and marked hyperlymphocytosis. It typically presents with profound leukocytosis, pulmonary hypertension, and respiratory failure. We report four cases of malignant pertussis in young infants. One patient underwent exchange transfusion. The case fatality rate was 50 %. Preventing these severe and often fatal cases-associated with high mortality and significant intensive care costs-relies primarily on vaccination. Immunization should be ensured for all infants and extended to adults at risk of transmitting the infection to unimmunized infants.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

